The test, treat, and track strategy is critical to containing the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The objective of this strategy is to contain the virus by quickly identifying both symptomatic and asymptomatic patients, performing contact tracing, and quarantining patients to reduce transmission.
From the pandemic’s onset, testing has been limited by supply chain problems at all levels. The unprecedented worldwide demand for viral diagnostic testing (ie, PCR tests) resulted in critical shortages of key supplies, including flocked nylon swabs for collecting samples and viral transport media (VTM) used for preserving and transporting samples.
LabNova has Virus Transport Media! Were pleased to announce we now have media designed to move virus testing samples, including COVID-19, from point A to B. Each lot of virus transport media (VTM) is manufactured under strict guidelines as outlined by Pursuant to the Ministry of Health’s Decision No.
4055/QD-BYT of September 23, 2020, is sterile, and undergoes quality control before release, meaning it is ready for use upon arrival.
LabNova has expanded the production capacity for its range of viral transport media. This strategy enables the company to not only continue supplying these important products in periods of high demand but also to offer the best pricing available for products of this type.
